English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  50699379    Online Users :  378
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"| kao j h"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 26-71 of 71  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-12T02:44:40Z Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial Liu C.-H; | Liu C.-J; | Huang C.-F; | Lin J.-W; | Dai C.-Y; | Liang C.-C; | Huang J.-F; | Hung P.-H; | Tsai H.-B; | Tsai M.-K; | Lee C.-Y; | Chen S.-I; | Yang S.-S; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chuang W.-L; | Yu M.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:39Z Looking into the crystal ball: biomarkers for outcomes of HBV infection HUNG-CHIH YANG; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:39Z Hepatitis B virus: New therapeutic perspectives Lin C.-L; | HUNG-CHIH YANG; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:39Z Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naive Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study Liu C.-H; | Sheng W.-H; | Sun H.-Y; | Hsieh S.-M; | Lo Y.-C; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Liu W.-C; | Chen P.-J; | Chen D.-S; | Hung C.-C; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:38Z Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection Yang W.-T; | Wu L.-W; | Tseng T.-C; | Chen C.-L; | HUNG-CHIH YANG; | Su T.-H; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Liu C.-J; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:38Z Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:37Z More viral mutants, less HBsAg clearance? One size may not fit all Tseng T.-C; | HUNG-CHIH YANG; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:37Z Pegylated IFN-�\ suppresses hepatitis C virus by promoting the DAPK-mTOR pathway Liu W.-L; | HUNG-CHIH YANG; | Hsu C.-S; | Wang C.-C; | Wang T.-S; | Kao J.-H; | Chen D.-S.
臺大學術典藏 2021-07-12T02:44:36Z Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Wang C.-C; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:36Z Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection Liu C.-H; | Liu C.-J; | Su T.-H; | Fang Y.-J; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:35Z Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis Su T.-H; | Shiau C.-W; | Jao P; | Yang N.-J; | Tai W.-T; | Liu C.-J; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-H; | Huang K.-W; | Hu T.-C; | Huang Y.-J; | Wu Y.-M; | Chen L.-J; | Chen P.-J; | Chen D.-S; | Chen K.-F; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:35Z Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients Lee M.-H; | Huang C.-F; | Lai H.-C; | Lin C.-Y; | Dai C.-Y; | Liu C.-J; | Wang J.-H; | Huang J.-F; | Su W.-P; | HUNG-CHIH YANG; | Kee K.-M; | Yeh M.-L; | Chuang P.-H; | Hsu S.-J; | Huang C.-I; | Kao J.-T; | Chen C.-C; | Chen S.-H; | Jeng W.-J; | Yang H.-I; | Yuan Y; | Lu S.-N; | Sheen I.-S; | Liu C.-H; | Peng C.-Y; | Kao J.-H; | Yu M.-L; | Chuang W.-L; | Chen C.-J.
臺大學術典藏 2021-07-12T02:44:34Z A noninvasive diagnosis of hepatic fibrosis by BioFibroScore? in chronic hepatitis C patients Liu C.-H; | Liu C.-J; | Hong C.-M; | Su T.-H; | HUNG-CHIH YANG; | Chen K.-M; | Huang Y.-P; | Yeh Y.-M; | Tien H.-L; | Liu Y.-C; | Kao J.-H; | Chen D.-S; | Chen P.-J.
臺大學術典藏 2021-07-12T02:44:33Z Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Liou J.-M; | Liu C.-H; | Chen C.-L; | Chen P.-J; | Chen D.-S; | Liu C.-J; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:33Z Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan Liu C.-H; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:33Z Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection Liu C.-H; | Chen Y.-S; | Wang S.-S; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:32Z Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection Liu C.-H; | Sun H.-Y; | Liu C.-J; | Sheng W.-H; | Hsieh S.-M; | Lo Y.-C; | Liu W.-C; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Hung C.-C; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:32Z Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection Tseng T.-C; | Liu C.-J; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Kuo S.F.-T; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:31Z Acoustic radiation force impulse US imaging: Liver stiffness in patients with chronic hepatitis B with and without antiviral therapy Su T.-H; | Liao C.-H; | Liu C.-H; | Huang K.-W; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-J; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:30Z Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B Papatheodoridis G.V; | Manolakopoulos S; | Su T.-H; | Siakavellas S; | Liu C.-J; | Kourikou A; | HUNG-CHIH YANG; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:30Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Liu C.-H; | Huang Y.-J; | Yang S.-S; | Chang C.-H; | Yang S.-S; | Sun H.-Y; | Liu C.-J; | Liu W.-C; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Hung C.-C; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Profile and value of FIB-4 in patients with dual chronic hepatitis C and B Liu C.-J; | Tseng T.-C; | Yang W.-T; | Su T.-H; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan Liu C.-H; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Hong C.-M; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:29Z Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus HUNG-CHIH YANG; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:28Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H; | Liu C.-J; | Tseng T.-C; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Wu S.-J; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:27Z Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis Liu C.-H; | Shih Y.-L; | Yang S.-S; | Lin C.-L; | Fang Y.-J; | Cheng P.-N; | Chen C.-Y; | Peng C.-Y; | Hsieh T.-Y; | Chiu Y.-C; | Su T.-H; | Liu C.-J; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:27Z Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection Liu C.-H; | Su T.-H; | Liu C.-J; | Hong C.-M; | HUNG-CHIH YANG; | Tseng T.-C; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:26Z Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism Su T.-H; | HUNG-CHIH YANG; | Tseng T.-C; | Chou S.-W; | Lin C.-H; | Liu C.-H; | Liu C.-J; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:26Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H; | Liao S.-H; | Hong C.-M; | Liu C.-J; | Tseng T.-C; | Liu C.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Adhoute X; | Bourli?re M; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:25Z Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis Su T.-H; | Peng C.-Y; | Tseng T.-C; | HUNG-CHIH YANG; | Liu C.-J; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:25Z High Level of Hepatitis B Core�VRelated Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load Tseng T.-C; | Liu C.-J; | Hsu C.-Y; | Hong C.-M; | Su T.-H; | Yang W.-T; | Chen C.-L; | HUNG-CHIH YANG; | Huang Y.-T; | Fang-Tzu Kuo S; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:24Z HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis Tseng T.-C; | Liu C.-J; | Chang C.T; | Su T.-H; | Yang W.-T; | Tsai C.-H; | Chen C.-L; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:24Z Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy Tseng T.-C; | Peng C.-Y; | Hsu Y.-C; | Su T.-H; | Wang C.-C; | Liu C.-J; | HUNG-CHIH YANG; | Yang W.-T; | Lin C.-H; | Yu M.-L; | Lai H.-C; | Tanaka Y; | Nguyen M.H; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:23Z Hepatitis B reactivation: diagnosis and management Huang S.-C; | HUNG-CHIH YANG; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:23Z Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data Hong C.-M; | Liu C.-H; | Su T.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen Y.-W; | Kao J.-H; | Liu C.-J.
臺大學術典藏 2021-07-12T02:44:23Z Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing Yang Y.-C; | Chen Y.-H; | Kao J.-H; | Ching C; | Liu I.-J; | Wang C.-C; | Tsai C.-H; | Wu F.-Y; | Liu C.-J; | Chen P.-J; | Chen D.-S; | HUNG-CHIH YANG
臺大學術典藏 2021-07-12T02:44:22Z Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943�V2020) HUNG-CHIH YANG; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:22Z Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer Su T.-H; | Tseng T.-C; | Liu C.-J; | Chou S.-W; | Liu C.-H; | HUNG-CHIH YANG; | Chen P.-J; | Chen D.-S; | Chen C.-L; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:21Z Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan Su H.-J; | Kao J.-H; | Tseng T.-C; | HUNG-CHIH YANG; | Su T.-H; | Chen P.-J; | Liu C.-J.
臺大學術典藏 2021-07-12T02:44:21Z High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy Chang W.-Y; | Chiu Y.-C; | Chiu F.-W; | Hsu Y.-C; | Tseng T.-C; | Cheng P.-N; | Yang S.-S; | Liu C.-J; | Su T.-H; | HUNG-CHIH YANG; | Liu C.-H; | Chen P.-J; | Chen D.-S; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:21Z Relationship between serum gamma-glutamyl transferase level and colorectal adenoma Hong T.-C; | HUNG-CHIH YANG; | Chen C.-L; | Kao J.-H; | Liu C.-J; | Chen M.-J; | Wang H.-Y; | Kuo Y.-C; | Yu L.-Y; | Hu K.-C.
臺大學術典藏 2021-07-12T02:44:20Z Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease Huang S.-C; | Su H.-J; | Kao J.-H; | Tseng T.-C; | HUNG-CHIH YANG; | Su T.-H; | Chen P.-J; | Liu C.-J.
臺大學術典藏 2021-07-12T02:44:20Z Direct comparison of biopsy techniques for hepatic malignancies Huang S.-C; | Liang J.-D; | Hsu S.-J; | Hong T.-C; | HUNG-CHIH YANG; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:19Z Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load Tseng T.-C; | Liu C.-J; | Yang W.-T; | Hsu C.-Y; | Hong C.-M; | Su T.-H; | Tsai C.-H; | Chen C.-L; | HUNG-CHIH YANG; | Liu C.-H; | Chen H.-H; | Chen P.-J; | Kao J.-H.
臺大學術典藏 2021-07-12T02:44:18Z Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters Lin S.-R; | Yang T.-Y; | Peng C.-Y; | Lin Y.-Y; | Dai C.-Y; | Wang H.-Y; | Su T.-H; | Tseng T.-C; | Liu I.-J; | Cheng H.-R; | Shen Y.-C; | Wu F.-Y; | Liu C.-J; | Chen D.-S; | Chen P.-J; | HUNG-CHIH YANG; | Kao J.-H.

Showing items 26-71 of 71  (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page